Evidence map›Paper›PMID 39598797›Full record

ArticleMolecules (Basel, Switzerland)2024

Crystallographic Fragment Screening of a Bifunctional Proline Catabolic Enzyme Reveals New Inhibitor Templates for Proline Dehydrogenase and L-Glutamate-γ-semialdehyde Dehydrogenase.

Kaylen R Meeks, Alexandra N Bogner, Jay C Nix, John J Tanner

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaylen R MeeksDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0001-9024-6255
Alexandra N BognerDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0002-0358-422X
Jay C NixMolecular Biology Consortium, Advanced Light Source, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA.ORCID 0000-0002-4041-4975
John J TannerDepartment of Biochemistry, University of Missouri, Columbia, MO 65211, USA.ORCID 0000-0001-8314-113X

Funding

User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Gregory L Hura · 2017 to 2026
$28.6M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
Investigating the Proline Cycle as a Potential Cancer Therapy TargetR01GM132640 · NIGMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI Donald F Becker, JOHN J TANNER · 2020 to 2026
$1.9M
NIGMS NIH HHS P30 GM124165NIGMS NIH HHS P30 GM124169NIGMS NIH HHS R01 GM132640NIGMS NIH HHS R01GM132640NIH HHS S10 OD021527
6 · The paper itself

Abstract

The proline catabolic pathway consisting of proline dehydrogenase (PRODH) and L-glutamate-γ-semialdehyde (GSAL) dehydrogenase (GSALDH) catalyzes the four-electron oxidation of L-proline to L-glutamate. Chemical probes to these enzymes are of interest for their role in cancer and inherited metabolic disease. Here, we report the results of a crystallographic fragment-screening campaign targeting both enzymes. A unique aspect of our approach is the screening of both enzymes simultaneously using crystals of the bifunctional PRODH-GSALDH enzyme, proline utilization A (PutA). A 288-fragment library from Zenobia was screened

Indexed as

Catalytic DomainEnzyme InhibitorsProlineProline OxidaseBinding SitesCrystallography, X-RayGlutamate-5-Semialdehyde DehydrogenaseHumansModels, MolecularEnzyme InhibitorsGlutamate-5-Semialdehyde DehydrogenaseProlineProline Oxidasealdehyde dehydrogenaseenzyme inhibitionflavoenzymefragment-based lead discoveryproline catabolismX-ray crystallography

Identifiers

PMID39598797
PMCPMC11596857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.